Drug discovery efforts have expanded beyond the traditional approaches of small molecules and antibodies to include cells.

This approach seeks to address safety challenges associated with traditional bispecifics by selectively engaging a cytotoxic T-cell subset ... Alloy’s antibody discovery capabilities to advance ...

The discovery of microbial-sensing proteins ... generates antibody-secreting B cells and cytotoxic T cells that are specific and efficient at targeting pathogen. Unfortunately, this process ...

Then, they tested how well suppressor cells carrying different payloads could counteract cytotoxic CAR T cells in vitro. The researchers cultured these different types of suppressor T cells along with ...

Vaccine is intended to stimulate T cell responses against targets across the entire genome of the selected virus, similar to company’s lead ...

VXM01 stimulates the patient's immune system to activate VEGFR2-specific, cytotoxic T-cells (so-called killer cells). These immune killer cells then actively destroy cells in the tumor vasculature ...